Case Report: Low-frequency tibial nerve stimulation: demonstrating a novel therapeutic option for Fowler’s syndrome through a pilot case series - Summary - MDSpire
Advertisement
Case Report: Low-frequency tibial nerve stimulation: demonstrating a novel therapeutic option for Fowler’s syndrome through a pilot case series
To explore if low-frequency Transcutaneous Tibial Nerve Stimulation (TTNS) can improve symptoms of Fowler’s Syndrome.
Key Findings:
50% of participants (N = 3) showed a positive response to TTNS, with a median increase in voiding efficiency from 6.3% to 12.6%.
Two participants exhibited a negative response, with a median decrease in voiding efficiency from -3.6% to -20.9%.
The study suggests TTNS may significantly improve symptoms in some cases of Fowler’s Syndrome, with a p-value of <0.05 indicating statistical significance.
Interpretation:
The findings indicate potential therapeutic benefits of low-frequency TTNS for patients with Fowler’s Syndrome, warranting further clinical investigation.
Limitations:
Small sample size (N = 6) limits generalizability.
Short duration of study with no follow-up assessments.
Lack of diversity in the participant sample may affect the applicability of results.
Conclusion:
TTNS shows promise as a non-invasive treatment for Fowler’s Syndrome, providing a foundation for future research, particularly larger studies to validate these findings.
Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)
